160 related articles for article (PubMed ID: 11339922)
21. Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
Armitage JO
N Engl J Med; 2005 Mar; 352(12):1250-2. PubMed ID: 15788502
[No Abstract] [Full Text] [Related]
22. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case].
Gamboa Domínguez A; Pita Ramírez L; Hurtado Monroy R; Angeles-Angeles A
Rev Invest Clin; 1992; 44(3):393-8. PubMed ID: 1283228
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of primary gastric non-Hodgkin's lymphoma with chemotherapy and radiotherapy.
Tsukada K; Arima K; Ohosone Y; Hanada T; Mita S; Harada K; Matsuoka Y; Irimajiti S; Fukuda J
Intern Med; 1992 Mar; 31(3):368-72. PubMed ID: 1377061
[TBL] [Abstract][Full Text] [Related]
25. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
Eich HT; Diehl V; Görgen H; Pabst T; Markova J; Debus J; Ho A; Dörken B; Rank A; Grosu AL; Wiegel T; Karstens JH; Greil R; Willich N; Schmidberger H; Döhner H; Borchmann P; Müller-Hermelink HK; Müller RP; Engert A
J Clin Oncol; 2010 Sep; 28(27):4199-206. PubMed ID: 20713848
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of malignant lymphoma: 12 years' experience with 109 patients. 2). Treatment of non-Hodgkin's lymphoma].
Furukawa Y; Takagi S; Tsuboyama A; Tsunoda S; Akashi M; Komatsu N; Takeda K; Muroi K; Akutsu M; Ohsaka A
Rinsho Ketsueki; 1987 Sep; 28(9):1544-52. PubMed ID: 3437516
[No Abstract] [Full Text] [Related]
28. An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications.
Bang SM; Cheong JW; Yang WI; Hahn JS
Yonsei Med J; 2005 Jun; 46(3):425-30. PubMed ID: 15988816
[TBL] [Abstract][Full Text] [Related]
29. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
[TBL] [Abstract][Full Text] [Related]
30. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
Vose JM; Anderson JR; Bierman PJ; Bast M; Weisenburger D; Chan WC; Bishop MR; Armitage JO
Semin Hematol; 1994 Apr; 31(2 Suppl 3):4-8. PubMed ID: 7521065
[No Abstract] [Full Text] [Related]
31. [Our experiences in treating patients with Hodgkin disease in the last decade].
Simon Z; Keresztes K; Miltényi Z; Ress Z; Váróczy L; Vadász G; Gergely L; Illés A
Orv Hetil; 2007 Apr; 148(15):675-82. PubMed ID: 17416575
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
Dodwell DJ; de Campos ES; Radford JA
Drugs; 1992 Jul; 44(1):1-8. PubMed ID: 1379906
[No Abstract] [Full Text] [Related]
33. Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study.
Kluin-Nelemans HC; Zagonel V; Anastasopoulou A; Bron D; Roozendaal KJ; Noordijk EM; Musson H; Teodorovic I; Maes B; Carbone A; Carde P; Thomas J
J Natl Cancer Inst; 2001 Jan; 93(1):22-30. PubMed ID: 11136838
[TBL] [Abstract][Full Text] [Related]
34. Primary non-Hodgkin's lymphoma of the urinary bladder.
Melekos MD; Matsouka P; Fokaefs E; Pantazakos A; Repanti M
Eur Urol; 1992; 21(1):85-8. PubMed ID: 1606990
[TBL] [Abstract][Full Text] [Related]
35. Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.
Gordon LI; Andersen J; Colgan J; Glick J; Resnick GD; O'Connell M; Cassileth PA
Cancer; 1995 Feb; 75(3):865-73. PubMed ID: 7530168
[TBL] [Abstract][Full Text] [Related]
36. Intermediate and high-grade gastric non-Hodgkin's lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy.
Haim N; Leviov M; Ben-Arieh Y; Epelbaum R; Freidin N; Reshef R; Ben-Shahar M
Leuk Lymphoma; 1995 Apr; 17(3-4):321-6. PubMed ID: 8580802
[TBL] [Abstract][Full Text] [Related]
37. Primary non-Hodgkin's lymphoma of the uterine cervix successfully treated by neoadjuvant chemotherapy: case report.
Szánthó A; Bálega J Já; Csapó Z; Sréter L Lí; Matolcsy A; Papp Z
Gynecol Oncol; 2003 Apr; 89(1):171-4. PubMed ID: 12694673
[TBL] [Abstract][Full Text] [Related]
38. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
[TBL] [Abstract][Full Text] [Related]
39. How can we determine the role of radiotherapy in the treatment of localized aggressive non-Hodgkin's lymphoma?
Gemici C; Salepci T
J Clin Oncol; 2007 Jul; 25(19):2857; author reply 2857-8. PubMed ID: 17602093
[No Abstract] [Full Text] [Related]
40. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
